Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levles in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor
Susumu Ogawa, Kazuhisa Takeuchi, Takefumi Mori, Kazuhiro Nako, Sadayoshi Ito
Dive into the research topics of 'Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levles in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor'. Together they form a unique fingerprint.